KEGG Orthology (KO) - Homo sapiens (human)

[ Brite menu | Organism menu | Download htext | Download json ]

1st Level  2nd Level  3rd Level  4th Level 

     KO
 09100 Metabolism
 
 09120 Genetic Information Processing
 
 09130 Environmental Information Processing
 
 09140 Cellular Processes
 
   09141 Transport and catabolism
 
   09143 Cell growth and death
     04110 Cell cycle [PATH:hsa04110]
     04111 Cell cycle - yeast
     04112 Cell cycle - Caulobacter
     04113 Meiosis - yeast
     04114 Oocyte meiosis [PATH:hsa04114]
     04210 Apoptosis [PATH:hsa04210]
       8743 TNFSF10; TNF superfamily member 10
       8797 TNFRSF10A; TNF receptor superfamily member 10a
       8795 TNFRSF10B; TNF receptor superfamily member 10b
       356 FASLG; Fas ligand
       355 FAS; Fas cell surface death receptor
       8772 FADD; Fas associated via death domain
       7124 TNF; tumor necrosis factor
       7132 TNFRSF1A; TNF receptor superfamily member 1A
       8717 TRADD; TNFRSF1A associated via death domain
       8837 CFLAR; CASP8 and FADD like apoptosis regulator
       841 CASP8; caspase 8
       843 CASP10; caspase 10
       839 CASP6; caspase 6
       836 CASP3; caspase 3
       840 CASP7; caspase 7
       637 BID; BH3 interacting domain death agonist
       581 BAX; BCL2 associated X, apoptosis regulator
       578 BAK1; BCL2 antagonist/killer 1
       56616 DIABLO; diablo IAP-binding mitochondrial protein
       5414 SEPTIN4; septin 4
       27429 HTRA2; HtrA serine peptidase 2
       54205 CYCS; cytochrome c, somatic
       317 APAF1; apoptotic peptidase activating factor 1
       842 CASP9; caspase 9
       5551 PRF1; perforin 1
       3002 GZMB; granzyme B
       10376 TUBA1B; tubulin alpha 1b
       7277 TUBA4A; tubulin alpha 4a
       7278 TUBA3C; tubulin alpha 3c
       7846 TUBA1A; tubulin alpha 1a
       84790 TUBA1C; tubulin alpha 1c
       51807 TUBA8; tubulin alpha 8
       112714 TUBA3E; tubulin alpha 3e
       113457 TUBA3D; tubulin alpha 3d
       79861 TUBAL3; tubulin alpha like 3
       4170 MCL1; MCL1 apoptosis regulator, BCL2 family member
       71 ACTG1; actin gamma 1
       60 ACTB; actin beta
       6708 SPTA1; spectrin alpha, erythrocytic 1
       6709 SPTAN1; spectrin alpha, non-erythrocytic 1
       4000 LMNA; lamin A/C
       4001 LMNB1; lamin B1
       84823 LMNB2; lamin B2
       142 PARP1; poly(ADP-ribose) polymerase 1
       10038 PARP2; poly(ADP-ribose) polymerase 2
       10039 PARP3; poly(ADP-ribose) polymerase family member 3
       143 PARP4; poly(ADP-ribose) polymerase family member 4
       1676 DFFA; DNA fragmentation factor subunit alpha
       1677 DFFB; DNA fragmentation factor subunit beta
       2021 ENDOG; endonuclease G
       9131 AIFM1; apoptosis inducing factor mitochondria associated 1
       2081 ERN1; endoplasmic reticulum to nucleus signaling 1
       7186 TRAF2; TNF receptor associated factor 2
       3708 ITPR1; inositol 1,4,5-trisphosphate receptor type 1
       3709 ITPR2; inositol 1,4,5-trisphosphate receptor type 2
       3710 ITPR3; inositol 1,4,5-trisphosphate receptor type 3
       823 CAPN1; calpain 1
       824 CAPN2; calpain 2
       100506742 CASP12; caspase 12 (gene/pseudogene)
       9451 EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3
       1965 EIF2S1; eukaryotic translation initiation factor 2 subunit alpha
       468 ATF4; activating transcription factor 4
       1649 DDIT3; DNA damage inducible transcript 3
       1508 CTSB; cathepsin B
       1075 CTSC; cathepsin C
       1509 CTSD; cathepsin D
       8722 CTSF; cathepsin F
       1512 CTSH; cathepsin H
       1513 CTSK; cathepsin K
       1514 CTSL; cathepsin L
       1519 CTSO; cathepsin O
       1520 CTSS; cathepsin S
       1515 CTSV; cathepsin V
       1521 CTSW; cathepsin W
       1522 CTSZ; cathepsin Z
       329 BIRC2; baculoviral IAP repeat containing 2
       330 BIRC3; baculoviral IAP repeat containing 3
       331 XIAP; X-linked inhibitor of apoptosis
       332 BIRC5; baculoviral IAP repeat containing 5
       10018 BCL2L11; BCL2 like 11
       598 BCL2L1; BCL2 like 1
       596 BCL2; BCL2 apoptosis regulator
       1616 DAXX; death domain associated protein
       8737 RIPK1; receptor interacting serine/threonine kinase 1
       153090 DAB2IP; DAB2 interacting protein
       4217 MAP3K5; mitogen-activated protein kinase kinase kinase 5
       5599 MAPK8; mitogen-activated protein kinase 8
       5602 MAPK10; mitogen-activated protein kinase 10
       5601 MAPK9; mitogen-activated protein kinase 9
       572 BAD; BCL2 associated agonist of cell death
       3725 JUN; Jun proto-oncogene, AP-1 transcription factor subunit
       2353 FOS; Fos proto-oncogene, AP-1 transcription factor subunit
       7157 TP53; tumor protein p53
       8739 HRK; harakiri, BCL2 interacting protein
       9020 MAP3K14; mitogen-activated protein kinase kinase kinase 14
       1147 CHUK; component of inhibitor of nuclear factor kappa B kinase complex
       3551 IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta
       8517 IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
       4792 NFKBIA; NFKB inhibitor alpha
       4790 NFKB1; nuclear factor kappa B subunit 1
       5970 RELA; RELA proto-oncogene, NF-kB subunit
       5783 PTPN13; protein tyrosine phosphatase non-receptor type 13
       1647 GADD45A; growth arrest and DNA damage inducible alpha
       4616 GADD45B; growth arrest and DNA damage inducible beta
       10912 GADD45G; growth arrest and DNA damage inducible gamma
       7185 TRAF1; TNF receptor associated factor 1
       597 BCL2A1; BCL2 related protein A1
       472 ATM; ATM serine/threonine kinase
       55367 PIDD1; p53-induced death domain protein 1
       63970 TP53AIP1; tumor protein p53 regulated apoptosis inducing protein 1
       27113 BBC3; BCL2 binding component 3
       5366 PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1
       835 CASP2; caspase 2
       4803 NGF; nerve growth factor
       4914 NTRK1; neurotrophic receptor tyrosine kinase 1
       3562 IL3; interleukin 3
       3563 IL3RA; interleukin 3 receptor subunit alpha
       1439 CSF2RB; colony stimulating factor 2 receptor subunit beta
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
       5295 PIK3R1; phosphoinositide-3-kinase regulatory subunit 1
       5296 PIK3R2; phosphoinositide-3-kinase regulatory subunit 2
       8503 PIK3R3; phosphoinositide-3-kinase regulatory subunit 3
       5170 PDPK1; 3-phosphoinositide dependent protein kinase 1
       207 AKT1; AKT serine/threonine kinase 1
       208 AKT2; AKT serine/threonine kinase 2
       10000 AKT3; AKT serine/threonine kinase 3
       3265 HRAS; HRas proto-oncogene, GTPase
       3845 KRAS; KRAS proto-oncogene, GTPase
       4893 NRAS; NRAS proto-oncogene, GTPase
       5894 RAF1; Raf-1 proto-oncogene, serine/threonine kinase
       5604 MAP2K1; mitogen-activated protein kinase kinase 1
       5605 MAP2K2; mitogen-activated protein kinase kinase 2
       5594 MAPK1; mitogen-activated protein kinase 1
       5595 MAPK3; mitogen-activated protein kinase 3
K04721 TNFSF10; tumor necrosis factor ligand superfamily member 10
K04722 TNFRSF10A_B; tumor necrosis factor receptor superfamily member 10A/B
K04722 TNFRSF10A_B; tumor necrosis factor receptor superfamily member 10A/B
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K02373 FADD; FAS-associated death domain protein
K03156 TNF; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K04724 CFLAR; CASP8 and FADD-like apoptosis regulator
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04400 CASP10; caspase 10 [EC:3.4.22.63]
K04396 CASP6; caspase 6 [EC:3.4.22.59]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04397 CASP7; caspase 7 [EC:3.4.22.60]
K04726 BID; BH3 interacting domain death agonist
K02159 BAX; apoptosis regulator BAX
K14021 BAK; Bcl-2 homologous antagonist/killer
K10522 DIABLO; diablo
K16943 SEPT4; septin 4
K08669 HTRA2; HtrA serine peptidase 2 [EC:3.4.21.108]
K08738 CYC; cytochrome c
K02084 APAF1; apoptotic protease-activating factor
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K02539 MCL1; myeloid leukemia cell differntiation protein MCL-1
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K06114 SPTA; spectrin alpha
K06114 SPTA; spectrin alpha
K12641 LMNA; lamin A/C
K07611 LMNB; lamin B
K07611 LMNB; lamin B
K24070 PARP1; poly [ADP-ribose] polymerase 1 [EC:2.4.2.30]
K10798 PARP2_3_4; poly [ADP-ribose] polymerase 2/3/4 [EC:2.4.2.30]
K10798 PARP2_3_4; poly [ADP-ribose] polymerase 2/3/4 [EC:2.4.2.30]
K10798 PARP2_3_4; poly [ADP-ribose] polymerase 2/3/4 [EC:2.4.2.30]
K02310 DFFA; DNA fragmentation factor, 45 kD, alpha subunit
K02311 DFFB; DNA fragmentation factor, 40 kD, beta subunit [EC:3.-.-.-]
K01173 ENDOG; endonuclease G, mitochondrial
K04727 AIFM1; apoptosis-inducing factor 1 [EC:1.-.-.-]
K08852 ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [EC:2.7.11.1 3.1.26.-]
K03173 TRAF2; TNF receptor-associated factor 2 [EC:2.3.2.27]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K01367 CAPN1; calpain-1 [EC:3.4.22.52]
K03853 CAPN2; calpain-2 [EC:3.4.22.53]
K04741 CASP12; caspase 12 [EC:3.4.22.-]
K08860 EIF2AK3; eukaryotic translation initiation factor 2-alpha kinase 3 [EC:2.7.11.1]
K03237 EIF2S1; translation initiation factor 2 subunit 1
K04374 ATF4; cyclic AMP-dependent transcription factor ATF-4
K04452 DDIT3; DNA damage-inducible transcript 3
K01363 CTSB; cathepsin B [EC:3.4.22.1]
K01275 CTSC; cathepsin C [EC:3.4.14.1]
K01379 CTSD; cathepsin D [EC:3.4.23.5]
K01373 CTSF; cathepsin F [EC:3.4.22.41]
K01366 CTSH; cathepsin H [EC:3.4.22.16]
K01371 CTSK; cathepsin K [EC:3.4.22.38]
K01365 CTSL; cathepsin L [EC:3.4.22.15]
K01374 CTSO; cathepsin O [EC:3.4.22.42]
K01368 CTSS; cathepsin S [EC:3.4.22.27]
K01375 CTSL2; cathepsin V [EC:3.4.22.43]
K08569 CTSW; cathepsin W [EC:3.4.22.-]
K08568 CTSZ; cathepsin X [EC:3.4.18.1]
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K04725 XIAP; E3 ubiquitin-protein ligase XIAP [EC:2.3.2.27]
K08731 BIRC5; baculoviral IAP repeat-containing protein 5
K16341 BCL2L11; Bcl-2-like protein 11
K04570 BCL2L1; Bcl-2-like 1 (apoptosis regulator Bcl-X)
K02161 BCL2; apoptosis regulator Bcl-2
K02308 DAXX; death-associated protein 6
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K19901 DAB2IP; disabled homolog 2-interacting protein
K04426 MAP3K5; mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K02158 BAD; Bcl-2-antagonist of cell death
K04448 JUN; transcription factor AP-1
K04379 FOS; proto-oncogene protein c-fos
K04451 TP53; tumor protein p53
K02512 HRK; activator of apoptosis harakiri
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K02374 PTPN13; tyrosine-protein phosphatase non-receptor type 13
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K03172 TRAF1; TNF receptor-associated factor 1
K02162 BCL2A1; hematopoietic Bcl-2-related protein A1
K04728 ATM; serine-protein kinase ATM [EC:2.7.11.1]
K10130 LRDD; leucine-rich repeats and death domain-containing protein
K13773 TP53AIP1; p53-regulated apoptosis-inducing protein 1
K10132 BBC3; Bcl-2-binding component 3
K10131 PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1
K02186 CASP2; caspase 2 [EC:3.4.22.55]
K02582 NGFB; nerve growth factor, beta
K03176 NTRK1; neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
K04736 IL3; interleukin 3
K04737 IL3RA; interleukin 3 receptor alpha
K04738 CSF2RB; cytokine receptor common subunit beta
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K06276 PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
     04214 Apoptosis - fly
     04215 Apoptosis - multiple species [PATH:hsa04215]
     04216 Ferroptosis [PATH:hsa04216]
     04217 Necroptosis [PATH:hsa04217]
     04115 p53 signaling pathway [PATH:hsa04115]
     04218 Cellular senescence [PATH:hsa04218]
 
   09144 Cellular community - eukaryotes
 
   09145 Cellular community - prokaryotes
 
   09142 Cell motility
 
 09150 Organismal Systems
 
   09151 Immune system
     04640 Hematopoietic cell lineage [PATH:hsa04640]
     04610 Complement and coagulation cascades [PATH:hsa04610]
     04611 Platelet activation [PATH:hsa04611]
     04620 Toll-like receptor signaling pathway [PATH:hsa04620]
     04624 Toll and Imd signaling pathway
     04621 NOD-like receptor signaling pathway [PATH:hsa04621]
     04622 RIG-I-like receptor signaling pathway [PATH:hsa04622]
     04623 Cytosolic DNA-sensing pathway [PATH:hsa04623]
     04625 C-type lectin receptor signaling pathway [PATH:hsa04625]
     04650 Natural killer cell mediated cytotoxicity [PATH:hsa04650]
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       3812 KIR3DL2; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2
       3811 KIR3DL1; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
       115653 KIR3DL3; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3
       3803 KIR2DL2; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
       3802 KIR2DL1; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1
       3804 KIR2DL3; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3
       57292 KIR2DL5A; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A
       3821 KLRC1; killer cell lectin like receptor C1
       3824 KLRD1; killer cell lectin like receptor D1
       5777 PTPN6; protein tyrosine phosphatase non-receptor type 6
       5781 PTPN11; protein tyrosine phosphatase non-receptor type 11
       3383 ICAM1; intercellular adhesion molecule 1
       3384 ICAM2; intercellular adhesion molecule 2
       3683 ITGAL; integrin subunit alpha L
       3689 ITGB2; integrin subunit beta 2
       2185 PTK2B; protein tyrosine kinase 2 beta
       10451 VAV3; vav guanine nucleotide exchange factor 3
       7409 VAV1; vav guanine nucleotide exchange factor 1
       7410 VAV2; vav guanine nucleotide exchange factor 2
       5879 RAC1; Rac family small GTPase 1
       5880 RAC2; Rac family small GTPase 2
       5881 RAC3; Rac family small GTPase 3
       5058 PAK1; p21 (RAC1) activated kinase 1
       5604 MAP2K1; mitogen-activated protein kinase kinase 1
       5605 MAP2K2; mitogen-activated protein kinase kinase 2
       5594 MAPK1; mitogen-activated protein kinase 1
       5595 MAPK3; mitogen-activated protein kinase 3
       7124 TNF; tumor necrosis factor
       1437 CSF2; colony stimulating factor 2
       3458 IFNG; interferon gamma
       3806 KIR2DS1; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
       3808 KIR2DS3; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3
       3809 KIR2DS4; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4
       3810 KIR2DS5; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5
       100132285 KIR2DS2; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2
       3822 KLRC2; killer cell lectin like receptor C2
       3823 KLRC3; killer cell lectin like receptor C3
       9436 NCR2; natural cytotoxicity triggering receptor 2
       7305 TYROBP; transmembrane immune signaling adaptor TYROBP
       3932 LCK; LCK proto-oncogene, Src family tyrosine kinase
       102723407 IGH; immunoglobulin heavy variable 4-38-2-like
       2214 FCGR3A; Fc fragment of IgG receptor IIIa
       2215 FCGR3B; Fc fragment of IgG receptor IIIb
       9437 NCR1; natural cytotoxicity triggering receptor 1
       259197 NCR3; natural cytotoxicity triggering receptor 3
       2207 FCER1G; Fc fragment of IgE receptor Ig
       919 CD247; CD247 molecule
       7535 ZAP70; zeta chain of T cell receptor associated protein kinase 70
       6850 SYK; spleen associated tyrosine kinase
       3937 LCP2; lymphocyte cytosolic protein 2
       27040 LAT; linker for activation of T cells
       5335 PLCG1; phospholipase C gamma 1
       5336 PLCG2; phospholipase C gamma 2
       6452 SH3BP2; SH3 domain binding protein 2
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
       5295 PIK3R1; phosphoinositide-3-kinase regulatory subunit 1
       5296 PIK3R2; phosphoinositide-3-kinase regulatory subunit 2
       8503 PIK3R3; phosphoinositide-3-kinase regulatory subunit 3
       2534 FYN; FYN proto-oncogene, Src family tyrosine kinase
       6464 SHC1; SHC adaptor protein 1
       25759 SHC2; SHC adaptor protein 2
       53358 SHC3; SHC adaptor protein 3
       399694 SHC4; SHC adaptor protein 4
       2885 GRB2; growth factor receptor bound protein 2
       6654 SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1
       6655 SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2
       3265 HRAS; HRas proto-oncogene, GTPase
       3845 KRAS; KRAS proto-oncogene, GTPase
       4893 NRAS; NRAS proto-oncogene, GTPase
       369 ARAF; A-Raf proto-oncogene, serine/threonine kinase
       673 BRAF; B-Raf proto-oncogene, serine/threonine kinase
       5894 RAF1; Raf-1 proto-oncogene, serine/threonine kinase
       4277 MICB; MHC class I polypeptide-related sequence B
       100507436 MICA; MHC class I polypeptide-related sequence A
       80329 ULBP1; UL16 binding protein 1
       80328 ULBP2; UL16 binding protein 2
       79465 ULBP3; UL16 binding protein 3
       22914 KLRK1; killer cell lectin like receptor K1
       100528032 KLRC4-KLRK1; KLRC4-KLRK1 readthrough
       10870 HCST; hematopoietic cell signal transducer
       962 CD48; CD48 molecule
       51744 CD244; CD244 molecule
       5530 PPP3CA; protein phosphatase 3 catalytic subunit alpha
       5532 PPP3CB; protein phosphatase 3 catalytic subunit beta
       5533 PPP3CC; protein phosphatase 3 catalytic subunit gamma
       5534 PPP3R1; protein phosphatase 3 regulatory subunit B, alpha
       5535 PPP3R2; protein phosphatase 3 regulatory subunit B, beta
       4772 NFATC1; nuclear factor of activated T cells 1
       4773 NFATC2; nuclear factor of activated T cells 2
       5578 PRKCA; protein kinase C alpha
       5579 PRKCB; protein kinase C beta
       5582 PRKCG; protein kinase C gamma
       117157 SH2D1B; SH2 domain containing 1B
       4068 SH2D1A; SH2 domain containing 1A
       3459 IFNGR1; interferon gamma receptor 1
       3460 IFNGR2; interferon gamma receptor 2
       3439 IFNA1; interferon alpha 1
       3440 IFNA2; interferon alpha 2
       3441 IFNA4; interferon alpha 4
       3442 IFNA5; interferon alpha 5
       3443 IFNA6; interferon alpha 6
       3444 IFNA7; interferon alpha 7
       3445 IFNA8; interferon alpha 8
       3446 IFNA10; interferon alpha 10
       3447 IFNA13; interferon alpha 13
       3448 IFNA14; interferon alpha 14
       3449 IFNA16; interferon alpha 16
       3451 IFNA17; interferon alpha 17
       3452 IFNA21; interferon alpha 21
       3456 IFNB1; interferon beta 1
       3454 IFNAR1; interferon alpha and beta receptor subunit 1
       3455 IFNAR2; interferon alpha and beta receptor subunit 2
       8743 TNFSF10; TNF superfamily member 10
       8797 TNFRSF10A; TNF receptor superfamily member 10a
       8795 TNFRSF10B; TNF receptor superfamily member 10b
       356 FASLG; Fas ligand
       355 FAS; Fas cell surface death receptor
       3002 GZMB; granzyme B
       5551 PRF1; perforin 1
       836 CASP3; caspase 3
       637 BID; BH3 interacting domain death agonist
       353091 RAET1G; retinoic acid early transcript 1G
       154064 RAET1L; retinoic acid early transcript 1L
       135250 RAET1E; retinoic acid early transcript 1E
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K24232 KIR2DL5; killer cell immunoglobulin-like receptor 2DL5
K06541 KLRC1; killer cell lectin-like receptor subfamily C1
K06516 KLRD1; killer cell lectin-like receptor subfamily D member 1
K05697 PTPN6; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48]
K07293 PTPN11; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48]
K06490 ICAM1; intercellular adhesion molecule 1
K06523 ICAM2; intercellular adhesion molecule 2
K05718 ITGAL; integrin alpha L
K06464 ITGB2; integrin beta 2
K05871 PTK2B; focal adhesion kinase 2 [EC:2.7.10.2]
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04409 PAK1; p21-activated kinase 1 [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K03156 TNF; tumor necrosis factor superfamily, member 2
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K04687 IFNG; interferon gamma
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K24233 KLRC2_3; killer cell lectin-like receptor subfamily C2/3
K24233 KLRC2_3; killer cell lectin-like receptor subfamily C2/3
K06742 NCR2; natural cytotoxicity triggering receptor 2
K07992 TYROBP; TYRO protein tyrosine kinase binding protein
K05856 LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K06856 IGH; immunoglobulin heavy chain
K06463 FCGR3; low affinity immunoglobulin gamma Fc receptor III
K06463 FCGR3; low affinity immunoglobulin gamma Fc receptor III
K06741 NCR1; natural cytotoxicity triggering receptor 1
K06743 NCR3; natural cytotoxicity triggering receptor 3
K07983 FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma
K06453 CD3Z; CD3Z antigen, zeta polypeptide
K07360 ZAP70; tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K07361 LCP2; lymphocyte cytosolic protein 2
K07362 LAT; linker for activation of T cells
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K07984 SH3BP2; SH3-domain binding protein 2
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K06279 SHC1; SHC-transforming protein 1
K17447 SHC2; SHC-transforming protein 2
K17448 SHC3; SHC-transforming protein 3
K17449 SHC4; SHC-transforming protein 4
K04364 GRB2; growth factor receptor-binding protein 2
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K08845 ARAF; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K07985 MIC; MHC class I-related protein
K07985 MIC; MHC class I-related protein
K07986 ULBP; UL16 binding protein
K07986 ULBP; UL16 binding protein
K07986 ULBP; UL16 binding protein
K06728 KLRK1; killer cell lectin-like receptor subfamily K member 1
K06728 KLRK1; killer cell lectin-like receptor subfamily K member 1
K07988 HCST; hematopoietic cell signal transducer
K06479 CD48; CD48 antigen
K06582 CD244; natural killer cell receptor 2B4
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K02677 PRKCA; classical protein kinase C alpha type [EC:2.7.11.13]
K19662 PRKCB; classical protein kinase C beta type [EC:2.7.11.13]
K19663 PRKCG; classical protein kinase C gamma type [EC:2.7.11.13]
K07989 EAT2; EWS/FLI1 activated transcript 2
K07990 SH2D1A; SH2 domain protein 1A
K05132 IFNGR1; interferon gamma receptor 1
K05133 IFNGR2; interferon gamma receptor 2
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K04721 TNFSF10; tumor necrosis factor ligand superfamily member 10
K04722 TNFRSF10A_B; tumor necrosis factor receptor superfamily member 10A/B
K04722 TNFRSF10A_B; tumor necrosis factor receptor superfamily member 10A/B
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K01353 GZMB; granzyme B [EC:3.4.21.79]
K07818 PRF1; perforin 1
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04726 BID; BH3 interacting domain death agonist
K07987 RAET1; retinoic acid early transcript 1
K07987 RAET1; retinoic acid early transcript 1
K07987 RAET1; retinoic acid early transcript 1
     04612 Antigen processing and presentation [PATH:hsa04612]
     04660 T cell receptor signaling pathway [PATH:hsa04660]
     04658 Th1 and Th2 cell differentiation [PATH:hsa04658]
     04659 Th17 cell differentiation [PATH:hsa04659]
     04657 IL-17 signaling pathway [PATH:hsa04657]
     04662 B cell receptor signaling pathway [PATH:hsa04662]
     04664 Fc epsilon RI signaling pathway [PATH:hsa04664]
     04666 Fc gamma R-mediated phagocytosis [PATH:hsa04666]
     04670 Leukocyte transendothelial migration [PATH:hsa04670]
     04672 Intestinal immune network for IgA production [PATH:hsa04672]
     04062 Chemokine signaling pathway [PATH:hsa04062]
 
   09152 Endocrine system
 
   09153 Circulatory system
 
   09154 Digestive system
 
   09155 Excretory system
 
   09156 Nervous system
 
   09157 Sensory system
 
   09158 Development and regeneration
 
   09149 Aging
 
   09159 Environmental adaptation
 
 09160 Human Diseases
 
   09161 Cancer: overview
 
   09162 Cancer: specific types
 
   09163 Immune disease
     05310 Asthma [PATH:hsa05310]
     05322 Systemic lupus erythematosus [PATH:hsa05322]
     05323 Rheumatoid arthritis [PATH:hsa05323]
     05320 Autoimmune thyroid disease [PATH:hsa05320]
       3439 IFNA1; interferon alpha 1
       3440 IFNA2; interferon alpha 2
       3441 IFNA4; interferon alpha 4
       3442 IFNA5; interferon alpha 5
       3443 IFNA6; interferon alpha 6
       3444 IFNA7; interferon alpha 7
       3445 IFNA8; interferon alpha 8
       3446 IFNA10; interferon alpha 10
       3447 IFNA13; interferon alpha 13
       3448 IFNA14; interferon alpha 14
       3449 IFNA16; interferon alpha 16
       3451 IFNA17; interferon alpha 17
       3452 IFNA21; interferon alpha 21
       1493 CTLA4; cytotoxic T-lymphocyte associated protein 4
       7173 TPO; thyroid peroxidase
       7038 TG; thyroglobulin
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       3558 IL2; interleukin 2
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       356 FASLG; Fas ligand
       355 FAS; Fas cell surface death receptor
       5551 PRF1; perforin 1
       3002 GZMB; granzyme B
       959 CD40LG; CD40 ligand
       958 CD40; CD40 molecule
       3565 IL4; interleukin 4
       3567 IL5; interleukin 5
       3586 IL10; interleukin 10
       102723407 IGH; immunoglobulin heavy variable 4-38-2-like
       7253 TSHR; thyroid stimulating hormone receptor
       1081 CGA; glycoprotein hormones, alpha polypeptide
       7252 TSHB; thyroid stimulating hormone subunit beta
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K06538 CTLA4; cytotoxic T-lymphocyte-associated protein 4
K00431 TPO; thyroid peroxidase [EC:1.11.1.8]
K10809 TG; thyroglobulin
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05429 IL2; interleukin 2
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K05430 IL4; interleukin 4
K05428 IL5; interleukin 5
K05443 IL10; interleukin 10
K06856 IGH; immunoglobulin heavy chain
K04249 TSHR; thyrotropin receptor
K08522 CGA; glycoprotein hormones alpha chain
K05251 TSHB; thyrotropin subunit beta
     05321 Inflammatory bowel disease (IBD) [PATH:hsa05321]
     05330 Allograft rejection [PATH:hsa05330]
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       3592 IL12A; interleukin 12A
       3593 IL12B; interleukin 12B
       356 FASLG; Fas ligand
       355 FAS; Fas cell surface death receptor
       5551 PRF1; perforin 1
       3002 GZMB; granzyme B
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       3558 IL2; interleukin 2
       959 CD40LG; CD40 ligand
       958 CD40; CD40 molecule
       3458 IFNG; interferon gamma
       7124 TNF; tumor necrosis factor
       3565 IL4; interleukin 4
       3567 IL5; interleukin 5
       3586 IL10; interleukin 10
       102723407 IGH; immunoglobulin heavy variable 4-38-2-like
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K05429 IL2; interleukin 2
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K04687 IFNG; interferon gamma
K03156 TNF; tumor necrosis factor superfamily, member 2
K05430 IL4; interleukin 4
K05428 IL5; interleukin 5
K05443 IL10; interleukin 10
K06856 IGH; immunoglobulin heavy chain
     05332 Graft-versus-host disease [PATH:hsa05332]
       3569 IL6; interleukin 6
       3552 IL1A; interleukin 1 alpha
       3553 IL1B; interleukin 1 beta
       7124 TNF; tumor necrosis factor
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       3558 IL2; interleukin 2
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       356 FASLG; Fas ligand
       355 FAS; Fas cell surface death receptor
       5551 PRF1; perforin 1
       3002 GZMB; granzyme B
       3458 IFNG; interferon gamma
       3803 KIR2DL2; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
       3802 KIR2DL1; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1
       3804 KIR2DL3; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3
       57292 KIR2DL5A; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A
       3812 KIR3DL2; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2
       3811 KIR3DL1; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
       115653 KIR3DL3; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3
       3821 KLRC1; killer cell lectin like receptor C1
       3824 KLRD1; killer cell lectin like receptor D1
K05405 IL6; interleukin 6
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K03156 TNF; tumor necrosis factor superfamily, member 2
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05429 IL2; interleukin 2
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K04687 IFNG; interferon gamma
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K24232 KIR2DL5; killer cell immunoglobulin-like receptor 2DL5
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K06541 KLRC1; killer cell lectin-like receptor subfamily C1
K06516 KLRD1; killer cell lectin-like receptor subfamily D member 1
     05340 Primary immunodeficiency [PATH:hsa05340]
 
   09164 Neurodegenerative disease
 
   09165 Substance dependence
 
   09166 Cardiovascular disease
     05418 Fluid shear stress and atherosclerosis [PATH:hsa05418]
     05410 Hypertrophic cardiomyopathy (HCM) [PATH:hsa05410]
     05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) [PATH:hsa05412]
     05414 Dilated cardiomyopathy (DCM) [PATH:hsa05414]
     05416 Viral myocarditis [PATH:hsa05416]
       1525 CXADR; CXADR Ig-like cell adhesion molecule
       1604 CD55; CD55 molecule (Cromer blood group)
       2534 FYN; FYN proto-oncogene, Src family tyrosine kinase
       857 CAV1; caveolin 1
       25 ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase
       27 ABL2; ABL proto-oncogene 2, non-receptor tyrosine kinase
       5879 RAC1; Rac family small GTPase 1
       5880 RAC2; Rac family small GTPase 2
       5881 RAC3; Rac family small GTPase 3
       6444 SGCD; sarcoglycan delta
       6445 SGCG; sarcoglycan gamma
       6442 SGCA; sarcoglycan alpha
       6443 SGCB; sarcoglycan beta
       284217 LAMA1; laminin subunit alpha 1
       3908 LAMA2; laminin subunit alpha 2
       1605 DAG1; dystroglycan 1
       1756 DMD; dystrophin
       71 ACTG1; actin gamma 1
       60 ACTB; actin beta
       8672 EIF4G3; eukaryotic translation initiation factor 4 gamma 3
       1981 EIF4G1; eukaryotic translation initiation factor 4 gamma 1
       1982 EIF4G2; eukaryotic translation initiation factor 4 gamma 2
       595 CCND1; cyclin D1
       841 CASP8; caspase 8
       637 BID; BH3 interacting domain death agonist
       54205 CYCS; cytochrome c, somatic
       842 CASP9; caspase 9
       836 CASP3; caspase 3
       4625 MYH7; myosin heavy chain 7
       4624 MYH6; myosin heavy chain 6
       959 CD40LG; CD40 ligand
       958 CD40; CD40 molecule
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       5551 PRF1; perforin 1
       3683 ITGAL; integrin subunit alpha L
       3689 ITGB2; integrin subunit beta 2
       3383 ICAM1; intercellular adhesion molecule 1
       102723407 IGH; immunoglobulin heavy variable 4-38-2-like
K06788 CXADR; coxsackievirus and adenovirus receptor
K04006 DAF; decay accelerating factor
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K06278 CAV1; caveolin 1
K06619 ABL1; abelson tyrosine-protein kinase 1 [EC:2.7.10.2]
K08887 ABL2; abelson tyrosine-protein kinase 2 [EC:2.7.10.2]
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K12563 SGCD; delta-sarcoglycan
K12564 SGCG; gamma-sarcoglycan
K12565 SGCA; alpha-sarcoglycan
K12566 SGCB; beta-sarcoglycan
K05637 LAMA1_2; laminin, alpha 1/2
K05637 LAMA1_2; laminin, alpha 1/2
K06265 DAG1; dystroglycan 1
K10366 DMD; dystrophin
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K03260 EIF4G; translation initiation factor 4G
K03260 EIF4G; translation initiation factor 4G
K03260 EIF4G; translation initiation factor 4G
K04503 CCND1; G1/S-specific cyclin-D1
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04726 BID; BH3 interacting domain death agonist
K08738 CYC; cytochrome c
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K17751 MYH6_7; myosin heavy chain 6/7
K17751 MYH6_7; myosin heavy chain 6/7
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K07818 PRF1; perforin 1
K05718 ITGAL; integrin alpha L
K06464 ITGB2; integrin beta 2
K06490 ICAM1; intercellular adhesion molecule 1
K06856 IGH; immunoglobulin heavy chain
 
   09167 Endocrine and metabolic disease
     04930 Type II diabetes mellitus [PATH:hsa04930]
     04940 Type I diabetes mellitus [PATH:hsa04940]
       3630 INS; insulin
       2571 GAD1; glutamate decarboxylase 1
       2572 GAD2; glutamate decarboxylase 2
       5798 PTPRN; protein tyrosine phosphatase receptor type N
       5799 PTPRN2; protein tyrosine phosphatase receptor type N2
       1363 CPE; carboxypeptidase E
       3329 HSPD1; heat shock protein family D (Hsp60) member 1
       3382 ICA1; islet cell autoantigen 1
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       3592 IL12A; interleukin 12A
       3593 IL12B; interleukin 12B
       3558 IL2; interleukin 2
       3458 IFNG; interferon gamma
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       356 FASLG; Fas ligand
       355 FAS; Fas cell surface death receptor
       5551 PRF1; perforin 1
       3002 GZMB; granzyme B
       4049 LTA; lymphotoxin alpha
       7124 TNF; tumor necrosis factor
       3552 IL1A; interleukin 1 alpha
       3553 IL1B; interleukin 1 beta
K04526 INS; insulin
K01580 E4.1.1.15; glutamate decarboxylase [EC:4.1.1.15]
K01580 E4.1.1.15; glutamate decarboxylase [EC:4.1.1.15]
K07817 PTPRN; receptor-type tyrosine-protein phosphatase N [EC:3.1.3.48]
K07817 PTPRN; receptor-type tyrosine-protein phosphatase N [EC:3.1.3.48]
K01294 CPE; carboxypeptidase E [EC:3.4.17.10]
K04077 groEL; chaperonin GroEL
K19863 ICA1; islet cell auto antigen 1
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K05429 IL2; interleukin 2
K04687 IFNG; interferon gamma
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K05468 LTA; lymphotoxin alpha (TNF superfamily, member 1)
K03156 TNF; tumor necrosis factor superfamily, member 2
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
     04950 Maturity onset diabetes of the young [PATH:hsa04950]
     04932 Non-alcoholic fatty liver disease (NAFLD) [PATH:hsa04932]
     04931 Insulin resistance [PATH:hsa04931]
     04933 AGE-RAGE signaling pathway in diabetic complications [PATH:hsa04933]
     04934 Cushing syndrome [PATH:hsa04934]
 
   09171 Infectious disease: bacterial
 
   09172 Infectious disease: viral
 
   09174 Infectious disease: parasitic
 
   09175 Drug resistance: antimicrobial
 
   09176 Drug resistance: antineoplastic
 
 09180 Brite Hierarchies
 
 09190 Not Included in Pathway or Brite

[ KO | BRITE | KEGG2 | KEGG ]
Last updated: July 10, 2020